Smarter science, sharper strategy: Expert insights from ASCO® 2026

What ASCO 2026 revealed about the future of oncology congress engagement​

The Annual ASCO® Meeting is always a major moment in the oncology calendar, but this year felt particularly important. That wasn’t simply because of the sheer number of people in attendance or the volume of data presented, but because of what that data tells us about the pace, complexity, and direction of cancer care.​

The meeting raised an important question: how do pharmaceutical companies communicate increasingly complex science effectively?​

At ASCO 2026, the answer wasn’t simply bigger booths or more technology. It was creating congress experiences that help HCPs navigate complexity, engage with the science, and turn innovation into understanding. ASCO is over for another year, but what we’ve learned from it remains highly relevant to any company looking to maximize their investment at next year’s event – or indeed any future congress. ​​

What’s inside the eBook?​​

In this eBook, we explore:​

• Making a connection in the age of accelerated innovation ​
• What the best congress experiences got right at ASCO ​
• The future of congress engagement for life sciences companies​
• What ASCO means for oncology commercialization ​
• Why a connected approach is key to pharma congress success

Download the ASCO 2026 eBook​

Download our ASCO 2026 eBook to discover the key trends shaping oncology congress engagement and learn how to maximize the impact of your future congress investment.​